menu ☰
menu ˟

Study highlights improved publication rates of studies supporting FDA premarket approval of high-risk CV devices

07 Mar 2016
From 2011 to 2013, eight of 10 studies supporting FDA approval of novel, high-risk CV devices were published in peer-reviewed biomedical journals, an improvement from the 49% publishing rate for trials from 2000 to 2010, according to a research lette...

Click here to view the full article which appeared in Cardiology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.